PENG Block & PENG PRF
Recruiting · NCT07360093 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ankara City Hospital Bilkent
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The primary aim of this study is to prospectively compare the effects of the pericapsular nerve group (PENG) block alone and the combination of PENG block with pulsed radiofrequency (PRF) on pain intensity in patients with chronic hip pain. As a secondary aim, the effects of both treatment modalities on hip function are intended to be evaluated using valid and reliable functional assessment scales. Through this study, it is aimed to demonstrate the clinical contribution of adding PRF to the PENG block and to identify a more effective and longer-lasting approach for the interventional treatment of chronic hip pain.
Who can take part
Inclusion criteria
- Presence of chronic hip pain lasting at least 3 months
- Baseline Visual Analog Scale (VAS) score ≥ 4
- Clinical and/or radiological diagnosis of hip osteoarthritis
- Inadequate response to conservative treatments
Exclusion criteria
- Local or systemic infection at the intervention site
- Coagulopathy or inability to discontinue anticoagulant therapy
- Hip pain related to malignancy
- History of previous hip arthroplasty
- Severe neurological deficit
- Pregnancy or breastfeeding
Where it is running
1 location listed.
- Ankara Bilkent City Hospital - Ankara, Turkey (Türkiye)